Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
Sven H. Loosen, Maximilian Schulze‐Hagen, Philipp Bruners, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1503-1503
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments
Giovanni Marasco, Matteo Serenari, Matteo Renzulli, et al.
Journal of Gastroenterology (2020) Vol. 55, Iss. 10, pp. 927-943
Open Access | Times Cited: 87
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 4, pp. 432-448
Open Access | Times Cited: 53
Sleep Duration and Sarcopenia: An Updated Systematic Review and Meta-Analysis
Xiaoyan Li, Jie He, Qiuhua Sun
Journal of the American Medical Directors Association (2023) Vol. 24, Iss. 8, pp. 1193-1206.e5
Open Access | Times Cited: 28
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
Man Zhao, Xiaoling Duan, Xin Han, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 29
Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients
Sven H. Loosen, Maximilian Schulze‐Hagen, Tobias Püngel, et al.
Critical Care Explorations (2020) Vol. 2, Iss. 8, pp. e0171-e0171
Open Access | Times Cited: 47
Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
Ezio Lanza, Chiara Masetti, Gaia Messana, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0232371-e0232371
Open Access | Times Cited: 39
Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis
Chuan Jiang, Yanyan Wang, Wei Fu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 23
Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
Ezio Lanza, Chiara Masetti, Gaia Messana, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0241715-e0241715
Open Access | Times Cited: 33
A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma Patients
Shangyuan Wang, Xuanpu Zhang, Qi Chen, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 659-671
Open Access | Times Cited: 12
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy
Jingzhong Ouyang, Yi Yang, Yanzhao Zhou, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1519-1531
Closed Access | Times Cited: 12
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Jing Long, Xin Zhang, Wei Mi, et al.
Aging (2024)
Open Access | Times Cited: 4
Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization
Jin-Xing Zhang, Hai‐Tao Yan, Ding Ye, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1562-1569
Open Access | Times Cited: 18
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies
Sven H. Loosen, Markus S. Jördens, Berenike Schoon, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6181-6190
Open Access | Times Cited: 10
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy
Hongcai Yang, Tianhao Cong, Yingen Luo, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 175-189
Open Access | Times Cited: 3
Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients
Hanaa Badran, Maha Elsabaawy, Amr Ragab, et al.
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 11, pp. 3285-3290
Open Access | Times Cited: 26
Body mass index and skeletal muscle index are useful prognostic factors for overall survival after gastrectomy for gastric cancer
Eun Young Kim, Kyong‐Hwa Jun, Shinn Young Kim, et al.
Medicine (2020) Vol. 99, Iss. 47, pp. e23363-e23363
Open Access | Times Cited: 25
The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization
Tzu-Ping Chien, Song-Fong Huang, Wen‐Hui Chan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Effects of Exercise Training on Muscle Mass and Physical Function in Patients with Hepatocellular Carcinoma After Diagnosis: A Systematic Review
Camille Marcantei, Alexis Couret, James A. King, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 7, pp. 2667-2680
Closed Access | Times Cited: 2
Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma
Attapon Rattanasupar, Tanaporn Prateepchaiboon, Keerati Akarapatima, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE
Ji Hyae Lim, Kyung Won Kim, Yousun Ko, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
Gaël S. Roth, Yann Teyssier, Maxime Benhamou, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 36, pp. 5324-5337
Open Access | Times Cited: 12
An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation
Jelena Djokić Kovač, Aleksandar Ivanović, Tamara Alempijević, et al.
Radiology and Oncology (2021) Vol. 55, Iss. 2, pp. 130-143
Open Access | Times Cited: 15
Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
Jie Chen, Yongjian Chen, Nan Jiang, et al.
The Oncologist (2021) Vol. 26, Iss. 8, pp. e1434-e1444
Open Access | Times Cited: 15
High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Qiang Li, Lei Zhang, Zhong-Heng Hou, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature
Maria Guarino, Valentina Cossiga, Chiara Becchetti, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 8, pp. 997-1006
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top